NASDAQ:IKNA
Ikena Oncology, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
ikenaoncology.comipo date
Mar 26, 2021
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small mole...Show More
Earnings
Earnings Release in 12 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus